Hims vs Trimi Health: Which GLP-1 Provider Is Better?
Short answer: Hims scores higher on our rubric, 7.9/10 against 4.2/10. Full reasoning, pricing and the cases where the other one wins are below.
Hims beats Trimi Health overall, scoring 7.9/10 vs 4.2/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; Trimi Health is $175/mo month-to-month. Choose Hims for men who want a well-known publicly-traded brand and fda-approved wegovy through the 2026 novo nordisk partnership, but should know going in that hims' customer-experience signal is weaker than smaller competitors. Choose Trimi Health for cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak trustpilot record plus no-pro-rating cancellation terms in exchange.
A side-by-side look at Hims and Trimi Health to help you decide. We compare them on:
- •Starting price per month
- •Our overall score, out of 10
- •Medication type, brand-name or compounded
- •Whether they accept insurance
- •Who each one is best for
Hims
#7 of 54The household name in men's telehealth, publicly traded as Hims & Hers Health (NYSE: HIMS). In 2026 Hims added FDA-approved brand-name Wegovy, Ozempic, Foundayo, and Zepbound paths and has since exited compounded semaglutide for new retail patients. The advertised medication floor is $149, but the required Weight Loss Membership adds $39 in month one and $149/month after that, so the all-in floor is $188 initially and $298 ongoing before any product- or dose-specific increase. Its parent still reports offering access to compounded GLP-1 medications on a limited scale (Q2 2026 results, filed with the SEC August 10, 2026). Brand recognition and product breadth are real strengths. The trade-off: Hims' verified Trustpilot rating is 3.0 stars across 8,286 reviews (May 2026), significantly below smaller competitors like Henry Meds (4.5) or Eden Health (4.5). The 1-star pool is 28%, the highest 1-star rate in our table, clustered around subscription/billing complaints.
Visit HimsTrimi Health
#52 of 54Telehealth platform for compounded semaglutide and tirzepatide. Weekly injections in vial-and-syringe format only, no pens, no oral option. Pricing is flat across all doses, with the consult and overnight shipping included. Prescriptions route through the Arora Health medical group (Dr. Sean Arora MD, medical director) and are filled by VialsRx and GreenwichRx, the same backend that powers Telos RX. Founded May 2024 per the site's own schema markup; no legal entity suffix or street address is disclosed.
Visit Trimi Health| Feature | Hims | Trimi Health |
|---|---|---|
| Our Score | 7.9/10 | 4.2/10 |
| Headline Price | $188 first month, then $298/mo | $175/mo month-to-month |
| Medication Type | Brand | Compounded |
| Insurance Accepted | No | No |
| Best For | Men who want a well-known publicly-traded brand and FDA-approved Wegovy through the 2026 Novo Nordisk partnership, but should know going in that Hims' customer-experience signal is weaker than smaller competitors | Cash-pay patients who want the cheapest flat-price compounded semaglutide we track ($99/mo on the annual plan) and will accept a weak Trustpilot record plus no-pro-rating cancellation terms in exchange |
| Watch out for | Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable. | Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds |
| Ranking | #7 | #52 |
| Get started | Visit Hims | Visit Trimi Health |
Pros & Cons Compared
Hims
Pros
- +Publicly traded company (NYSE: HIMS), SEC-filed financials, regulatory accountability that private competitors don't have.
- +2026 Novo Nordisk partnership, FDA-approved Wegovy injection, Wegovy pill, and Ozempic now available directly through Hims. Real brand-name access from a single platform.
- +Medication starts at $149/mo for Wegovy pill, Foundayo, and Ozempic pill; Wegovy or Ozempic pens start at $199 and Zepbound at $299. The required membership makes the lowest all-in path $188 in month one and $298/mo ongoing, and exact product or dose can cost more.
- +Polished app and web experience, among the best user interfaces in men's telehealth.
- +8,286 verified Trustpilot reviews is the second-largest review volume in our table (after Henry's 12,461), significant real-world adoption.
Cons
- −Pending federal enforcement action. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings, and Hims has not been found liable.
- −Trustpilot rating is 3.0 stars / 8,286 reviews (May 2026), significantly below Henry Meds (4.5), Eden Health (4.5), Yucca Health (4.6), MEDVi (4.4). The lowest customer-experience signal of any major brand we track.
- −28% of Trustpilot reviews are 1-star, the highest 1-star rate in our table. Top complaint themes: subscription handling, unexpected charges, customer service responsiveness.
- −Hims reviews span ALL their products (ED, hair loss, mental health, weight loss), not just GLP-1. But the rating still applies because most users don't separate experiences by product.
- −'Hims Oral Kit' is NOT a GLP-1, it's a non-GLP-1 metabolic combination (metformin + bupropion + topiramate + B12 + naltrexone). Do not confuse its $69 price with the current brand-name GLP-1 menu.
- −The $149 GLP-1 figures are medication-only. A required Weight Loss Membership costs $39 in month one and $149/mo ongoing, so a $149 medication path totals at least $188 initially and $298/mo after that.
- −Cash-pay only, Hims does not bill insurance, so an insured buyer may do better on a copay.
- −Generic high-volume support, large patient base means less personalized attention than smaller competitors.
Trimi Health
Pros
- +$99/mo compounded semaglutide on the annual plan (billed $1,188 once yearly) is among the cheapest flat recurring rates we track; tirzepatide annual is $125/mo ($1,500 yearly)
- +Flat pricing across all doses, your monthly price does not rise as your dose titrates up
- +Consult and overnight shipping included in the plan price, no add-on fees; HSA/FSA accepted, Klarna and Affirm financing available
- +Named medical director, Dr. Sean Arora MD of the Arora Health medical group, most compounded-only platforms name no one
- +Compounding pharmacies named: VialsRx (TX license #35264, site-claimed) and GreenwichRx, most competitors do not name theirs
- +Available in all 50 states plus DC per trytrimi.com/states
- +6-month money-back weight-loss promise published (conditions apply, read them before counting on it)
Cons
- −Trustpilot FELL from 4.6 earlier in 2026 to 3.4 across 71 reviews, ranking #62 of 70 in its category, recurring complaints cite account closures and withheld refunds
- −Once a prescription is signed, payments are final, no pro-rating, cancelling an annual plan mid-year forfeits the remainder. Full refund is available only BEFORE the prescription is signed
- −No legal entity disclosed, the site identifies only 'Trimi Health' with no LLC/Inc suffix and no street address (New York appears only in the site's schema markup)
- −Vial-and-syringe format only, no autoinjector pens, no oral option, no brand-name medications
- −LegitScript certification claimed but we could not verify it against LegitScript's registry
- −Mandatory arbitration clause in the terms
- −Retatrutide and orforglipron are listed as 'Preparing', roadmap items, not available today, do not enroll expecting them
- −Shares its medical group (Arora Health) and pharmacy (VialsRx) with Telos RX, a white-label backend relationship neither brand discloses on its own site
Our Verdict
Hims edges out Trimi Health with a score of 7.9/10 vs 4.2/10. Published pricing is not a like-for-like monthly comparison: Hims is $188 first month, then $298/mo; Trimi Health is $175/mo month-to-month.
Read Full Reviews
Related comparisons
More head-to-head comparisons involving Hims and Trimi Health.
- Hims vs Galafrom $149/mo
- Hims vs Yucca Healthfrom $146/mo
- Hims vs Wellorithmfrom $147/mo
- Trimi Health vs HealthRXfrom $99/mo
- Trimi Health vs Willowfrom $299/mo
- Trimi Health vs Hone Healthfrom $309/mo
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Our pick of these two: Hims · 7.9/10